Extracellular Prolidase (PEPD) Induces Anabolic Processes through EGFR, β1-integrin, and IGF-1R Signaling Pathways in an Experimental Model of Wounded Fibroblasts

• Published in: International journal of molecular sciences 2021-01, Vol.22 (2), p.942
• Main Authors: Baszanowska, Weronika, Misiura, Magdalena, Oscilowska, Ilona, Palka, Jerzy, Miltyk, Wojciech
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Biosynthesis; Cell growth; Cell viability; Collagen; Deoxyribonucleic acid; DNA; Epidermal growth factor; Epidermal growth factor receptors; Extracellular matrix; Fibroblasts; Gene expression; Grb2 protein; Growth factors; Insulin; Insulin-like growth factor I; Kinases; Metabolism; Metabolites; Phosphorylation; Prolidase; Proteins; Signal transduction; Skin; Tissue engineering; TOR protein; Wound healing
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22020942

The role of prolidase (PEPD) as a ligand of the epidermal growth factor receptor (EGFR) was studied in an experimental model of wound healing in cultured fibroblasts. The cells were treated with PEPD (1–100 nM) and analysis of cell viability, proliferation, migration, collagen biosynthesis, PEPD activity, and the expressions of EGFR, insulin-like growth factor 1 (IGF-1), and β1-integrin receptor including downstream signaling proteins were performed. It has been found that PEPD stimulated proliferation and migration of fibroblasts via activation of the EGFR-downstream PI3K/Akt/mTOR signaling pathway. Simultaneously, PEPD stimulated the expression of β1-integrin and IGF-1 receptors and proteins downstream to these receptors such as FAK, Grb2, and ERK1/2. Collagen biosynthesis was increased in control and “wounded” fibroblasts under PEPD treatment. The data suggest that PEPD-induced EGFR signaling may serve as a new attempt to therapy wound healing.